Lexaria Bioscience Corp. also files under LEXX, LEXG, LXRA; those filings are included. Filings under LXRP by Enertopia Corp. (CIK 0001346022) from Dec 16, 2014 to Dec 17, 2014 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Bunka Christopher | Director | Gift(G) | 100K | — | $0 |
| Jul 30, 2025 | Bunka Christopher | Director | Buy(P) | 12K | $0.91 | $11K |
| Jul 29, 2025 | Docherty John Martin | President & CSO, Director | Buy(P) | 5K | $0.93 | $5K |
| Jul 29, 2025 | Bunka Christopher | Director | Buy(P) | 16K | $0.92 | $14K |
| Jul 29, 2025 | Christopher Richard | Chief Executive Officer, Director | Buy(P) | 15K | $0.91 | $14K |
| Jul 29, 2025 | Carle Vanessa | Secretary | Buy(P) | 750 | $0.91 | $683 |
| Jul 29, 2025 | McKechnie William Edward | Director | Buy(P) | 5K | $0.91 | $5K |
| May 15, 2025 | Carle Vanessa | Secretary | Grant(A) | 15K | — | $0 |
| May 15, 2025 | Bhullar Baljinder | Director | Grant(A) | 11K | — | $0 |
| May 15, 2025 | Shankman Michael Elliot | Chief Financial Officer | Grant(A) | 50K | — | $0 |
| May 15, 2025 | Reese Albert L JR | Director | Grant(A) | 11K | — | $0 |
| May 15, 2025 | McKechnie William Edward | Director | Grant(A) | 11K | — | $0 |
| May 15, 2025 | Christopher Richard | Chief Executive Officer, Director | Grant(A) | 150K | — | $0 |
| May 15, 2025 | Bunka Christopher | Director | Grant(A) | 11K | — | $0 |
| May 15, 2025 | Baxter Nicholas W | Director | Grant(A) | 11K | — | $0 |
| May 15, 2025 | Docherty John Martin | President, Director | Grant(A) | 150K | — | $0 |
| Jan 7, 2025 | Bunka Christopher | Director | Grant(A) | 100K | — | $0 |
| Dec 3, 2024 | Christopher Richard | Chief Executive Officer | Buy(P) | 27K | $2.47 | $67K |
| Dec 2, 2024 | Christopher Richard | Chief Executive Officer | Buy(P) | 23K | $2.24 | $51K |
| Aug 12, 2024 | Turkel Catherine C. | Director | Buy(P) | 2K | $3.13 | $5K |
| Jul 31, 2024 | Carle Vanessa | Secretary | Sell(S) | 3K | $4.00 | $10K |
| Jul 26, 2024 | McKechnie William Edward | Director | Grant(A) | 12K | — | $0 |
| Jul 26, 2024 | Reese Albert L JR | Director | Grant(A) | 12K | — | $0 |
| Jul 26, 2024 | Turkel Catherine C. | Director | Grant(A) | 12K | — | $0 |
| Jul 26, 2024 | Baxter Nicholas W | Director | Grant(A) | 12K | — | $0 |
| May 14, 2024 | Carle Vanessa | Secretary | Option exercise(M) | 3K | — | $0 |
| May 14, 2024 | Carle Vanessa | Secretary | Option exercise(M) | 3K | $1.15 | $3K |
| Apr 26, 2024 | Turkel Catherine C. | Director | Grant(A) | 5K | — | $0 |
| Apr 26, 2024 | Baxter Nicholas W | Director | Grant(A) | 5K | — | $0 |
| Apr 26, 2024 | Reese Albert L JR | Director | Grant(A) | 5K | — | $0 |
| Apr 26, 2024 | McKechnie William Edward | Director | Grant(A) | 5K | — | $0 |
| Apr 26, 2024 | Bunka Christopher | Chief Executive Officer, Director | Grant(A) | 50K | — | $0 |
| Apr 26, 2024 | Docherty John Martin | President, Director | Grant(A) | 50K | — | $0 |
| Apr 26, 2024 | Carle Vanessa | Secretary | Grant(A) | 10K | — | $0 |
| Oct 26, 2023 | Carle Vanessa | Secretary | Grant(A) | 13K | — | $0 |
| Oct 26, 2023 | Docherty John Martin | President, Director | Grant(A) | 30K | — | $0 |
| Oct 26, 2023 | Bunka Christopher | Chief Executive Officer, Director | Grant(A) | 30K | — | $0 |
| Jul 25, 2023 | Turkel Catherine C. | Director | Grant(A) | 5K | — | $0 |
| Jul 25, 2023 | Reese Albert L JR | Director | Grant(A) | 5K | — | $0 |
| Jul 25, 2023 | Baxter Nicholas W | Director | Grant(A) | 5K | — | $0 |
| Jul 25, 2023 | McKechnie William Edward | Director | Grant(A) | 5K | — | $0 |
| Feb 9, 2023 | Turkel Catherine C. | Director | Buy(P) | 2K | $2.84 | $4K |
| Oct 14, 2022 | Downey Gregory | Chief Financial Officer | Buy(P) | 121 | $2.09 | $253 |
| Oct 13, 2022 | Bunka Christopher | Chief Executive Officer, Director | Buy(P) | 17K | $2.10 | $35K |
| Oct 12, 2022 | Baxter Nicholas W | Director | Grant(A) | 18K | — | $0 |
| Oct 12, 2022 | Bunka Christopher | Chief Executive Officer, Director | Buy(P) | 22K | $1.99 | $44K |
| Oct 12, 2022 | McKechnie William Edward | Director | Grant(A) | 18K | — | $0 |
| Oct 12, 2022 | Reese Albert L JR | Director | Grant(A) | 3K | — | $0 |
| Oct 12, 2022 | Turkel Catherine C. | Director | Grant(A) | 2K | — | $0 |
| Sep 2, 2022 | Turkel Catherine C. | Director | Grant(A) | 3K | — | $0 |
| Aug 29, 2022 | Downey Gregory | Chief Financial Officer | Grant(A) | 11K | — | $0 |
| Aug 29, 2022 | Carle Vanessa | Secretary | Grant(A) | 13K | — | $0 |
| Aug 29, 2022 | Docherty John Martin | President, Director | Grant(A) | 30K | — | $0 |
| Aug 29, 2022 | Bunka Christopher | Chief Executive Officer, Director | Grant(A) | 30K | — | $0 |
| May 24, 2022 | Reese Albert L JR | Director | Grant(A) | 5K | $1.96 | $10K |
| May 20, 2022 | Reese Albert L JR | Director | Grant(A) | 2K | $2.01 | $4K |
| May 19, 2022 | Reese Albert L JR | Director | Grant(A) | 2K | $2.01 | $3K |
| May 18, 2022 | Reese Albert L JR | Director | Grant(A) | 2K | $2.01 | $3K |
| Mar 8, 2022 | Reese Albert L JR | Director | Grant(A) | 3K | — | $0 |
| Mar 8, 2022 | McKechnie William Edward | Director | Grant(A) | 3K | — | $0 |
| Mar 8, 2022 | Baxter Nicholas W | Director | Grant(A) | 3K | — | $0 |
| Sep 1, 2021 | Carle Vanessa | Secretary | Grant(A) | 10K | — | $0 |
| Sep 1, 2021 | McKechnie William Edward | Director | Grant(A) | 2K | — | $0 |
| Sep 1, 2021 | Baxter Nicholas W | Director | Grant(A) | 2K | — | $0 |
| Sep 1, 2021 | Bunka Christopher | CEO, Director | Grant(A) | 15K | — | $0 |
| Sep 1, 2021 | Downey Gregory | Chief Financial Officer | Grant(A) | 10K | — | $0 |
| Sep 1, 2021 | Docherty John Martin | President, Director | Grant(A) | 15K | — | $0 |
| Jun 8, 2021 | McKechnie William Edward | Director | Grant(A) | 5K | — | $0 |
| Jun 8, 2021 | Bunka Christopher | CEO, Director | Grant(A) | 23K | — | $0 |
| Jun 8, 2021 | Downey Gregory | Chief Financial Officer | Grant(A) | 8K | — | $0 |
| Jun 8, 2021 | Baxter Nicholas W | Director | Grant(A) | 5K | — | $0 |
| Jun 8, 2021 | Carle Vanessa | Secretary | Grant(A) | 5K | — | $0 |
| Jun 8, 2021 | Docherty John Martin | President, Director | Grant(A) | 18K | — | $0 |
| May 7, 2021 | Docherty John Martin | President, Director | Other(J) | 18K | — | $0 |
| May 7, 2021 | McKechnie William Edward | Director | Other(J) | 5K | — | $0 |
| May 7, 2021 | Bunka Christopher | CEO, Director | Other(J) | 23K | — | $0 |
| May 7, 2021 | Downey Gregory | Chief Financial Officer | Other(J) | 8K | — | $0 |
| May 7, 2021 | Baxter Nicholas W | Director | Other(J) | 5K | — | $0 |
| May 7, 2021 | Carle Vanessa | Secretary | Other(J) | 5K | — | $0 |
| Apr 26, 2021 | Carle Vanessa | Secretary | Grant(A) | 13K | — | $0 |
| Apr 26, 2021 | McKechnie William Edward | Director | Grant(A) | 2K | — | $0 |
| Apr 26, 2021 | Downey Gregory | Chief Financial Officer | Grant(A) | 5K | — | $0 |
| Apr 26, 2021 | Bunka Christopher | CEO, Director, 10% Owner | Grant(A) | 26K | — | $0 |
| Apr 26, 2021 | Docherty John Martin | President, Director | Grant(A) | 18K | — | $0 |
| Apr 26, 2021 | Baxter Nicholas W | Director | Grant(A) | 2K | — | $0 |
| Feb 1, 2021 | Reese Albert L JR | Director | Grant(A) | 3K | — | $0 |
| Nov 10, 2020 | Bunka Christopher | CEO, Director, 10% Owner | Buy(P) | 10K | $0.20 | $2K |
| Nov 10, 2020 | Bunka Christopher | CEO, Director, 10% Owner | Buy(P) | 6K | $0.20 | $1K |
| Nov 10, 2020 | Bunka Christopher | CEO, Director, 10% Owner | Buy(P) | 26K | $0.19 | $5K |
| Nov 9, 2020 | Bunka Christopher | CEO, Director, 10% Owner | Buy(P) | 7K | $0.20 | $1K |
| Nov 9, 2020 | Bunka Christopher | CEO, Director, 10% Owner | Buy(P) | 22K | $0.20 | $4K |
| Nov 9, 2020 | Bunka Christopher | CEO, Director, 10% Owner | Buy(P) | 38K | $0.22 | $8K |
| Nov 9, 2020 | Bunka Christopher | CEO, Director, 10% Owner | Buy(P) | 10K | $0.20 | $2K |
| Nov 9, 2020 | Bunka Christopher | CEO, Director, 10% Owner | Buy(P) | 10K | $0.21 | $2K |
| Nov 9, 2020 | Bunka Christopher | CEO, Director, 10% Owner | Buy(P) | 8K | $0.20 | $2K |
| Nov 6, 2020 | Bunka Christopher | CEO, Director, 10% Owner | Buy(P) | 60K | $0.21 | $13K |
| Jul 23, 2020 | McKechnie William Edward | Director | Option exercise(M) | 110K | — | $0 |
| Jul 23, 2020 | McKechnie William Edward | Director | Option exercise(M) | 110K | $0.17 | $19K |
| May 6, 2020 | Bunka Christopher | CEO, Director, 10% Owner | Grant(A) | 200K | $0.23 | $46K |
| May 6, 2020 | Bunka Christopher | CEO, Director, 10% Owner | Grant(A) | 200K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Lexaria Bioscience Corp., SEC CIK 0001348362. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under LXRP and shows every filing by that issuer (also filed as LEXX, LEXG, LXRA). Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for LXRP